Home » hypercholesterolemia

hypercholesterolemia

May 16, 2018

FH Foundation, Color Launch Familial Hypercholesterolemia Genetic Testing Study

The study aims to understand the willingness of individuals with a clinical diagnosis of familial hypercholesterolemia and their family members to undergo confirmatory genetic testing.

Nov 13, 2017

Lipid Nanoparticle CRISPR Delivery Can Result in More Efficient Editing Than Viral Delivery

The MIT-led team that developed the delivery technique said that it was able to induce more than 80 percent editing of the Pcsk9 gene in the livers of mice. 

Aug 10, 2017

Color Moves Beyond Hereditary Cancer Testing With High Cholesterol Genetic Test

Premium

The latest offering puts the genetic testing company on the path toward becoming what it calls a preventive health service company.

Mar 22, 2016

Admera Health Broadens Test Portfolio With Cardiovascular Additions; Plans Liquid Biopsy Assays

Premium

Last week, the firm launched AtheroGxOne the second of two cardiovascular next-gen sequencing panels, and hopes to launch its first liquid biopsy test in 2017.

Nov 12, 2015

Progenika Biopharma Lands CE Mark for NGS Familial Hypercholesterolemia Test

The firm's Seqpro Lipo IS is the first approved NGS diagnostic assay for the disease, which affects one in 300 people.

Mar 11, 2015

Cholesterol Transport Linked to Diabetes Risk

Genetic study of familial hypercholesterolemia implicates link between type 2 diabetes risk and cholesterol transport.

Feb 13, 2015

Alnylam Aims to Release Multi-program Clinical Data in 1H 2015

Premium

The firm also said it aims to soon begin human studies for its hepatic porphyria treatment ALN-AS1 and to select a development candidate for its program in primary hyperoxaluria type 1.

Dec 12, 2014

Alnylam Begins Clinical Trials of ATTR, Hypercholesterolemia Drugs

Premium

Both drugs are administered subcutaneously using Alnylam's GalNAc conjugates.

Nov 13, 2014

Carriers of NPC1L1 Inactivating Mutations Have Lower Coronary Heart Disease Risk, Researchers Say

NEW YORK (GenomeWeb) – Naturally occurring mutations that disrupt NPC1L1 protein function are associated with lower plasma low-density lipoprotein levels and a reduced risk of coronary heart disease, investigators from the Myocardial Infarction Genetics Consortium

Nov 05, 2014

Study IDs New Loci, Explains 5 Percent of Variation in Cholesterol-Lowering Effects of Statins

Premium

Originally published Nov. 4

Pages

The Scan

Make Sense of It All

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

Variations on Results

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

This Week in Nature

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

Of Many Minds

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.